Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuying Ma

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The <i>N</i> -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease InhibitorsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.
European Journal of Medicinal Chemistry|July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antiviralsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main ProteaseZhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Journal of Medicinal Chemistry|August 10, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main ProteaseZhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease InhibitorsKai S Yang, Xinyu R Ma, Yuying Ma, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The <i>N</i> -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease InhibitorsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
European Journal of Medicinal Chemistry|July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antiviralsYugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
ACS Central Science|March 1, 2022
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based AssayWenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, et al.
European Journal of Medicinal Chemistry|July 2, 2022
A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antiviralsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main ProteaseZhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Journal of Medicinal Chemistry|August 10, 2023
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main ProteaseZhi Zachary Geng, Sandeep Atla, Namir Shaabani, et al.
Antiviral Research|March 30, 2024
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitorsKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
An Azapeptide Platform in Conjunction with Covalent Warheads to Uncover High-Potency Inhibitors for SARS-CoV-2 Main ProteaseKaustav Khatua, Yugendar R Alugubelli, Kai S Yang, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease InhibitorsKai S Yang, Xinyu R Ma, Yuying Ma, et al.
Pageof 13